News & Events

Science-inspired artwork up for sale!

The 2nd Annual Taubman Institute Evening of Art + Science, held May 14 at the Detroit Institute of Arts, was a gala success. 

Select artwork, below, still is available for purchase, with proceeds to benefit the Taubman Institute's Emerging Scholars Program. For more information, contact Glen Walker at  (734) 615-7282 or This email address is being protected from spambots. You need JavaScript enabled to view it. .

The sale includes artwork originating from the collaboration of Taubman Scholars and the creators, as well as items donated from the private collections of friends of he Taubman Institute.


Brian Barr
Heart-ache and the Thousand Natural Shocks, 2015
Collage/Photograph
60 x 42 in (152.4 x 106.68 cm)
Framed

$1,500

 

 

 

 

 

 

Untitled (A-10) , 2008-2009
Oil on masonite
12 x 16 in (30.48 x 40.64 cm)
Courtesy of the artist
Signed

 $1,950

 

 

 

 


Aspen Mays
Kedra Corey (triptych), 2015
Archival inkjet print
15 x 11 in (38.1 x 27.94 cm)
Framed

 $1,500

 

 

Run'n Free , 1985
Ceramic and paint
17 x 25 x 5 in (43.18 x 63.5 x 12.7 cm)
Courtesy of a private collector
Signed

 $6,000

 

 

 

Color Bands, 2000
Linocut printed in colors on wove paper
24 x 24 in (60.96 x 60.96 cm)
39 of 75
Courtesy of a private collector
Signed in pencil
 
$6,250

 

 

 

 

 

 

 

9/4/2014 Detroit, MI, 2015
CVS photo kiosk prints
24 x 24 in (60.96 x 60.96 cm)

 $2,250

 

 

 

 

 

 
Birth of Venus , 2005
Oil painting
54 x 72 in (137.16 x 182.88 cm)
Courtesy of a private collector

 $6,250

 

 

 

 

 

 

Bio-Culture - MECC , 2015
Taxidermy hump of dromedary, Polyamide (Selective Laser Sintering), Stainless steel, Print on plexi glass, Print on wood (molecular structure of Propionyl-CoA)
51.2 x 47.2 x 80 in (130.05 x 119.89 x 203.2 cm)

 $22,245

 

 

 

 

 

 

 

 

Tangle, Mouse, 2015
Plywood and silk organza
20 x 32 x 24 in (50.8 x 81.28 x 60.96 cm)

 $3,500

 

 

 

 

 

 

 
Hyperoxia , 2015
Pom-poms, cardboard, gorilla glue and hot glue paint
18 x 20 x 18 in (45.72 x 50.8 x 45.72 cm)

 $750

 

 

 

 

 

About the Art + Science Collaboration

Twenty physician-researchers of the A. Alfred Taubman Medical Research Institute – global thought leaders in areas like cancer, cardiovascular health, ALS and more – teamed up this year with painters, sculptors, jewelers and other creative virtuosos for mind-bending conversations about the intersection of discovery and creativity in their respective fields.

In visits to one another’s labs and studios, the artists and scientists found common ground in the process each uses to leap challenges, to refine new techniques and to test novel hunches and ideas.

In the laboratory, the process leads to life-giving new treatments and cures. In the studio, the journey of inspiration results in works of beauty and expression.  The resulting one-of-a-kind creations — in media ranging from oils to textiles to gemstones — are sold to fund the Taubman Institute's Emerging Scholars grants.

Aimed at launching the laboratories of U-M's best and brightest young doctors, these grants of $50,000 per year for three years help ensure the next generation of medical breakthroughs.  In just a few short years, Taubman Emerging Scholars have initiated nine human clinical trials of new treatments in fields ranging from cancer to inflammatory diseases.  With 16 Emerging Scholars now being supported – and two dozen more worthy candidates vetted and ready for funding – it’s a program that aims for, and achieves, fast results for patients who can’t wait.

Ch. 4 covers institute's unique art + science program

Detroit's WDIV television station (Ch. 4) interviews Taubman Scholar Tom Gardner, M.D., M.S., and artist Osman Khan, who recently teamed up as part of the Taubman Institute's annual artist-scientist collaboration.

Along with 19 other scholar-artist pairs, Gardner and Khan discussed the similarities between research and artistic creation.  The resulting artworks were auctioned May 14 at An Evening of Art + Science to raise funds for the institute's Emerging Scholars Program, which supports early-career clinician-scientists.

Click here to view the WDIV report. 

Taubman Scholar develops improved test for prostate cancer

Use of Mi-Prostate Score would reduce unneeded biopsies

Research led by Taubman Emerging Scholar Scott Tomlins, M.D., Ph.D., has led to a  new urine-based test providing improved prostate cancer detection – including detecting more aggressive forms of prostate cancer – compared to traditional models based on prostate serum antigen, or PSA, levels.

The test, developed at the University of Michigan Comprehensive Cancer Center, is called Mi-Prostate Score, or MiPS. It combines PSA with two markers for prostate cancer, T2:ERG and PCA3, both of which can be detected through a urine sample. The test has been available clinically since September 2013.

“Around 50 percent of men who undergo a prostate biopsy will not have cancer. We need better ways to manage elevated PSA and determine who really needs to have a biopsy. MiPS gives men and their doctors better information to help make those decisions,” says lead study author Tomlins,  assistant professor of pathology and urology at the University of Michigan Medical School.

The study looked at a total of 1,977 men who were undergoing prostate biopsy because of elevated PSA levels. Using urine samples, the researchers conducted MiPS testing and compared results to various combinations of PSA, PCA3, T2:ERG and other PSA-based risk calculators. They assessed how well the individual biomarkers and combinations of biomarkers predicted the likelihood of cancer and the likelihood of high-risk cancer – the aggressive type that needs immediate treatment.

The test reports individual risk estimates for prostate cancer and high grade cancer. Each patient’s personal threshold for choosing to undergo biopsy may vary, so there is no single cutoff for a “positive” result.

However, using one MiPS cutoff score to decide whether to biopsy patients would reduce the number of biopsies by one-third, while delaying the diagnosis of only about 1 percent of high-risk prostate cancers. The study is published in European Urology.

“MiPS gives men a more individualized risk assessment for prostate cancer, so that men concerned about their serum PSA levels can have a more informed conversation with their doctor about next steps in their care,” Tomlins says. A cost/benefit analysis of MiPS is being conducted.

PCA3 is approved by the U.S. Food and Drug Administration for prostate cancer risk assessment in men with a previous negative biopsy. Most of the men involved in this study were undergoing initial biopsy, suggesting MiPS can be useful earlier in the process.

The test is part of broader efforts at the University of Michigan to improve prostate cancer diagnosis, particularly detecting the type of cancer that requires immediate and aggressive treatment.

Mi-Prostate Score is available to anyone but requires a request from a doctor. For further information, call the University of Michigan's MLabs at 800-862-7284. Patients with questions about prostate cancer detection or treatment may call the U-M Cancer AnswerLine at 800-865-1125.

 

Information for those wishing to make a donation

At the Taubman Institute, we have been deeply touched by the calls and e-mails from individuals wishing to honor the life and legacy of A. Alfred Taubman through a donation to support lifesaving medical research.

To make a gift online via credit card, simply click here. 

Checks made payable to the University of Michigan may be mailed to:

A. Alfred Taubman Medical Research Institute
109 Zina Pitcher Place
5017 A. Alfred Taubman Biomedical Science Research Bldg.
Ann Arbor, MI 48109-2200

For assistance, please phone: 734-615-7282

If you are interested in making a major gift to support the Emerging Scholars Program, please contact development officer Maria Muller at  734-355-5233  or This email address is being protected from spambots. You need JavaScript enabled to view it. .

The University of Michigan has 501(c)(3) non-profit tax exempt status; our federal tax ID number is 38-6006309.

Our deepest thanks to all who have extended condolences and memorial tributes on the passing of Mr. Taubman.

 

Taubman Scholars reflect on A. Alfred Taubman

The mission of the Taubman Institute is to support eminent clinician-scientists — doctors taking on the dual role of physician and laboratory researcher in their zeal to speed new cures and treatments to their patients.  

Taubman Scholar grants allow these dedicated healers the freedom they need to pursue “high-risk, high-reward” science that in a few short years has led to more than 50 human clinical trials of new therapies.

Here, the Taubman Scholars share their reflections on the extraordinary contributions that Alfred Taubman has made to the future of medical science.

The Taubman Institute that is the refection of Mr. Taubman’s unselfishness has enabled a line of scientific inquiry that would not have occurred otherwise. Mr. Taubman and I had two one-on-one conversations, the first when he came to my office to consider my application as a Scholar, and the second more recently. On both occasions he inspired me with his determination, forward looking approach and kindness. I am forever grateful to have had the chance to know him and his family.

 

Thomas Gardner, M.D., M.S.
Healthy Eyes Taubman Scholar
Professor, Ophthalmology and Visual Sciences
Professor, Molecular and Integrative Physiology
Director, Juvenile Diabetes Foundation Retinopathy Center

 

 

To me, the Taubman Institute represents a celebration of a life well-lived, and a deep desire to make a difference for the good of the world. Mr. Taubman was always a visionary, striving to invent and reinvent. He was amazingly successful at that. I’m fortunate to have made Mr. Taubman's acquaintance, and am very proud to be part of the Taubman Institute.

 

Alon Kahana, M.D., Ph.D.
Assistant Professor and Helmut F. Stern Professor
Ophthalmology and Visual Sciences
Kellogg Eye Center, University of Michigan

 

 

When one has an inspiration to further high risk, high reward translational science, and operationalizes it, it has the most meaning for those patients who ultimately benefit from that inspiration and kindness. Mr. Taubman’s inspiration has motivated young as well as established scientists to heed his call to provide help for those afflicted with disease. The world is in a better place through that inspiration.

 

John M. Carethers, M.D.
John G. Searle Professor and Chair
Department of Internal Medicine

 

 

Mr. Taubman supported the research in my laboratory. He took the time to listen to me and to encourage the progress we were making towards better treatments for people who were infected with HIV. He helped me and the trainees in my lab. I am grateful for this and I am honored to have known him. He will be greatly missed.

 

Kathleen Collins, M.D., Ph.D.
Internal Medicine Collegiate Professor of HIV Research
Professor of Internal Medicine
Professor of Microbiology and Immunology

 

 

Alfred was a great and inspiring man. The establishment of the Taubman Institute was grounded in his desire to end human suffering from diseases including dementia, Lou Gehrig's disease, and childhood cancer. I am grateful to have met him. His kindness and passion for science to improve the human condition were both inspiring and a great motivator for me and my research team.

 

Valerie P. Castle, M.D.
Chair, Pediatrics and Communicable Diseases
Ravitz Foundation Professor of Pediatrics and Communicable Diseases

Professor of Pediatric Hematology/Oncology

 

 

I got to know Mr. Taubman about four years ago when I was being considered to become a Taubman Scholar. I showed him our work in treating liver tumors with a unique radiation therapy approach and was amazed at how quickly he understood the concepts and of the quality of the questions he asked. He was 100 percent on target and very perceptive.

 

In addition to his well-known passion for architecture and for building, he had a keen mind and depth of insight well beyond what I would expect from the average intelligent lay person. Maybe it is because radiation therapy depends on three dimensional thinking, and his "architectural brain" was already trained that way.

He will be missed.

 

Theodore S Lawrence, M.D., Ph.D., FASCO, FASTRO
Max S. Wicha M.D. Distinguished Professor of Oncology
Director, University of Michigan Comprehensive Cancer Center
Chair, Department of Radiation Oncology

 

 

Alfred Taubman's vision in creating the Taubman Medical Institute has been transformative. His generosity has allowed us to form the collaborations and pursue the type of high risk-high reward research that is critical to advance our field.

 

Srijan Sen, M.D., Ph.D.
Assistant Professor
Psychiatry, Neuroscience and Bioinformatics
Molecular and Behavioral Neuroscience Institute

 

 

It is difficult to convey what Mr. Taubman did for me, personally, to push forward new lines of research in my own lab. I was fortunate to have lunch with Mr. Taubman last year at his office, where his curiosity about many things, including science, was on full display – impressive indeed! I saw firsthand his deep commitment to spur Taubman Scholars toward new insights into human disease and, from that knowledge, better therapies. Mr. Taubman made, and will continue to make, a major impact on what many of us do in our labs and at the bedside.

 

Henry L. Paulson, M.D., Ph.D.
Professor, Department of Neurology
Lucille Groff Professor of Neurology

 

 

Some men and women achieve immortality. It may be through the memory and deeds of their children. It may be through the legacy of their work. It may be through the achievements of others that they have made possible.

 

A. Alfred Taubman, mentor, patron, and friend to so many of us, achieves immortality through each of these. Through the A. Alfred Taubman Medical Institute, which Alfred and his family founded and support, and in which I am a scholar, physician-scientists are finding meaningful treatments for the most difficult neurological diseases of our time—ALS or Lou Gehrig’s disease, Alzheimer’s disease, Parkinson’s disease, spinal cord injury and stroke.

 

Ongoing initiatives, which helped and continue to help scores of patients with terrible disease, were always front-and-center in our conversations. Alfred’s insightful and incisive questions, his encouragement and support to break through barriers and challenges, and his shared delight in what we have achieved, never failed to inspire. He uniquely provided both the faith that makes the seemingly impossible possible and the critical resources to make it happen.

 

He has been a giant, on whose shoulders we can all stand. I will miss Alfred as a mentor and as a friend, I will remember him for his curiosity and his warmth and his unwavering support, and my patients will thank him for all that he has made possible, for the rest of our days. For who he has been and for what he has done, A. Alfred Taubman is truly immortal.

 

Parag G. Patil, M.D., Ph.D.
Assistant Professor of Neurosurgery, Neurology, Anesthesiology, and Biomedical Engineering

 

I am deeply saddened by our loss of Mr. Taubman. Since the beginning of my academic career in medicine he has inspired me in countless ways. The admiration that I have for him lies not only in his overwhelming support of me and my lab efforts, but by his compassion and his unyielding desire to change to world. I will miss him dearly. His legacy will live on through us all.

 Erika Newman, MD, FAAP, FACS
Assistant Professor of Pediatric Surgery
Surgical Director, Mott Solid Tumor Oncology Program (MSTOP)

 

His vision and tremendous generosity for supporting research has touched many, including me. He has left an indelible legacy here at Michigan and I will personally remember him for his wit, curiosity and genuine interest in knowing about my own and others research. An irreplaceable loss, my heart and prayers go out to his family and loved ones.

 

Pavan Reddy, M.D.

Moshe Talpaz Professor of Translational Oncology

Professor of Medicine

Co-Director, Hematological Malignancies and BMT Program

Associate Division Chief, Hematology-Oncology

 

 

 

The support from Mr. Tubman and the Emerging Scholars Program has been instrumental in my ability to advance translational research and I am so greatful for his amazing generosity.  He will be sorely missed, but his vision for research advancement will live on through all those whom his gifts have touched.

 Katherine A. Gallagher, M.D.

Assistant Professor of Surgery

 

 

 

What I felt after all of my interactions with Alfred was his joy of accomplishment.  He always seemed to have such a positive attitude.   Whether he was talking about his career or the next thing he was going to do in life, there wasn’t a doubt in his mind that he couldn’t do it.  It was infectious. 

Charles F. Burant, M.D., Ph.D.

Dr. Robert C. and Veronica Atkins Professor of Metabolism
Professor of Internal Medicine
Professor of Molecular and Integrative Physiology

 

 

Mr. Taubman was an extraordinary pioneer, innovator and visionary and I had the good fortune to first meet him in 2011 when I joined the Taubman Medical Research Institute as an Emerging Scholar.  Of the discussions I’ve had with Mr. Taubman over the years, several of which incidentally were on salmon fishing in my home country Iceland, I have always been struck by his inquisitive mind and openness.  Through his vision the work that he has enabled at the Taubman Medical Research Institute will have a world-wide impact in the years and decades to come. Thank you Mr. Taubman for all you have done

Johann Gudjonsson, M.D., Ph.D.

Assistant Professor, Dermatology

 

 

Mr. Taubman’s generosity and commitment to the University of Michigan has impacted my every phase of my career, beginning as a medical student studying in the Taubman Library or seeing patients in the Taubman Health Care Center to starting my laboratory in the A. Alfred Taubman Basic Sciences Research Building. More recently, being named the A. Alfred Taubman Emerging Scholar allowed me to get to know Mr. Taubman and experience firsthand his commitment to the University, young clinician scientists, and translational research that can directly impact patients.

 

 

 Scott Tomlins, M.D., Ph.D.

The A. Alfred Taubman Emerging Scholar

Assistant Professor, Pathology

 

 

Dr. Eva Feldman commemorates Alfred Taubman

A. Alfred Taubman, one of the world's leading champions of bold approaches to medical research, passed away at age 91 on April 18, 2015.  One of his enduring legacies will be the groundbreaking work of the clincian-scientists whose work has been accelaterated by the charge from the Taubman Institute to use unrestricted financial grants to follow their hunches and establish new paradigms in the development of cures and diseases for mankind's most difficult diseases.

“All of us who knew and worked with Mr. Taubman are deeply grieving his passing. But at the same time we are grateful for his extreme generosity, wise leadership and limitless ability to make change happen,” said Eva L. Feldman, M.D., Ph.D., director of the A. Alfred Taubman Medical Research Institute at the University of Michigan.

“The source of Mr. Taubman’s greatness lies in his bold, visionary thinking and his willingness to take bold risks that changed conventional thinking in every area he touched. The immeasurable benefits his work will bring to future generations will be the legacy of his passion, his inspiration and his unmatched ability to achieve grand results.”

 

 

University of Michigan Statement on the passing of A. Alfred Taubman

Statement from Mark S. Schlissel, M.D., Ph.D., president of the University of Michigan

The University of Michigan family was saddened to learn of the passing of A. Alfred Taubman. We have lost a dear friend and educational partner, one of the genuine leaders and best.

Our hearts go out to his family, friends, loved ones, and all those he has touched with his considerable generosity and commitment to a better University of Michigan.

The University of Michigan – and the opportunities we provide to our students – would not be the same without Mr. Taubman. He valued state-of-the-art facilities for teaching, research and patient care, and he was always mindful of supporting the activities that take place inside the university and the buildings that bear his name. He provided scholarships to our students, enhanced the way we teach architecture and urban planning, and gave our faculty the opportunity to launch unparalleled medical research initiatives.

Mr. Taubman’s legacy at the University of Michigan will forever reflect his generosity, impact, and passion for advancing opportunities for our campus, its students and the health and well-being of all members of society. His strong support of the University of Michigan during his life will be further augmented by the provisions he made in his will for the university’s future.

He was a great man– successful, generous and warm. But he also was someone who held all those around him to high standards. He helped drive excellence at Michigan not just through his philanthropy, but by the advice he gave to multiple presidents and the fact that he held us to account to get the very most out of everything we did.

Our entire community will deeply miss Mr. Taubman and his commitment to our campus and students.

Two CME credits offered at Taubman Emerging Scholars Symposium

2nd Annual Taubman Emerging Scholars Symposium

Six talented young leaders of the next generation of medical researchers will speak April 27 at the 2nd Annual Emerging Scholars Symposium of the A. Alfred Taubman Medical Research Institute. The symposium will take place from 10 a.m. to noon at the Kahn Auditorium of the A. Alfred Taubman Biomedical Science Research Building.

These groundbreaking clinician-scientists on the faculty of the University of Michigan Medical School  are making remarkable strides toward treatments for life-altering conditions like prostate cancer, wounds that won't heal, inflammatory skin conditions, deteriorating joints, vision loss and neurological diseases.

Physicians attending may be eligible for 2 CME credits per the following criteria:
 
 
Program objectives:
This symposium will summarize recently-published peer-reviewed research by the Emerging Scholars of the A. Alfred Taubman Medical Research Institute. New information regarding the treatment of various conditions will be presented by the clinician-scientists who authored the research. 
 
At the conclusion of the seminar, participants will be able to implement:
 Better approaches in the treatment of patients with joint damage
 New approaches in the use of diagnostic imaging for patients with neurodegenerative diseases
 Approaches to the management of impaired wound healing in patients with diabetes
 The latest knowledge regarding inflammatory skin diseases
 New approaches to muscle regeneration in patients ophthalmology
 The latest knowledge regarding the genomics of prostate cancer

Who should attend:
The symposium is open to University of Michigan clinicians and research scientists, as well as other primary care practitioners and public health scholars interested in the most recent discovery regarding these prevalent diseases.

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Michigan Medical School designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

2nd Annual Taubman Emerging Scholars Symposium April 27

Six talented young leaders of the next generation of medical researchers will speak April 27 at the 2nd Annual Emerging Scholars Symposium of the A. Alfred Taubman Medical Research Institute. 

These groundbreaking clinician-scientists on the faculty of the University of Michigan Medical School  are making remarkable strides toward treatments for life-altering conditions like prostate cancer, wounds that won't heal, inflammatory skin conditions, deteriorating joints, vision loss and neurological diseases. 

Their work is made possible in part by grants from the Taubman Instittue's Emerging Scholars Program.  Aimed at launching the laboratories of U-M's best and brightest young doctors, these grants of $50,000 per year for three years help ensure that we all will benefit from the next generation of medical breakthroughs. 

In just a few short years, Taubman Emerging Scholars have initiated nine human clinical trials of new treatments in fields ranging from cancer to inflammatory diseases.  With 16 Emerging Scholars now being supported – and two dozen more worthy candidates vetted and ready for funding – it’s a program that aims for, and achieves, fast results for patients who can’t wait.

All are welcome to attend the symposium; no registration is required.  2 CME credits are available for qualifying physician attendees.

Featured speakers are:

Asheesh Bedi, M.D.  ~ "Challenges and advances in joint preservation of the hip."

Bradley Foerster, M.D., Ph.D.  ~ "Capturing disease and guiding treatments for ALS through imaging."

Katherine Gallagher, M.D.  ~ "Histone methylation changes in myeloid cells influence inflammation and impair wound healing in type II diabetes."

Johann Gudjonsson, M.D., Ph.D.  ~ "Psoriasis – genetics and associated diseases."

Alon Kahana, M.D., Ph.D. ~ "Muscle regeneration and cellular reprogramming: the value of going the wrong way!"

Scott Tomlins, M.D., Ph.D. ~ "Translating the cancer genome to the clinic."

 

Details:

2nd Annual Emerging Scholars Symposium

10 a.m. - noon
D. Dan and Betty Kahn Auditorium
A. Alfred Taubman Biomedical Science Research Building
109 Zina Pitcher Place, Ann Arbor, MI  48109
No registration required ~ All welcome

Coffee and pastries served at 9:30 a.m.

 

CME credit may be available for qualifying physician attendees:  

Program objectives:

This symposium will summarize recently-published peer-reviewed research by the Emerging Scholars of the A. Alfred Taubman Medical Research Institute. New information regarding the treatment of various conditions will be presented by the clinician-scientists who authored the research. 

At the conclusion of the seminar, participants will be able to implement:
 Better approaches in the treatment of patients with joint damage

 New approaches in the use of diagnostic imaging for patients with neurodegenerative diseases

 Approaches to the management of impaired wound healing in patients with diabetes

 The latest knowledge regarding inflammatory skin diseases

 New approaches to muscle regeneration in patients ophthalmology

 The latest knowledge regarding the genomics of prostate cancer

Who should attend:
The symposium is open to University of Michigan clinicians and research scientists, as well as other primary care practitioners and public health scholars interested in the most recent discovery regarding these prevalent diseases.

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Michigan Medical School designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Party in Detroit for Medical Research!

 


Populux event May 12 will celebrate the creative connection of artists and scientists


Ann Arbor — Detroit’s hot new nightclub Populux will host “Cures Are an Art Form,” an innovative benefit party being staged May 12 on behalf of the A. Alfred Taubman Medical Research Institute.


Detroit-area native Ethan Daniel Davidson and other musical performers will entertain and the event will feature a festive selection of beer, wine and hors d’oeuvres.  

Cutting-edge young doctor-scientists from the University of Michigan Medical School will be on hand to discuss their latest discoveries, many of which are funded by the Taubman Institute at U-M.

For the second year in a row, they have teamed up with painters, sculptors, jewelers and other creative virtuosos for mind-bending conversations about the intersection of discovery and creativity in their respective fields.

The resulting one-of-a-kind creations will be auctioned off two days later on May 14 at ticketed gala at the Detroit Institute of Arts.

But supporters can take a sneak peak at some of the art pieces – in media ranging from oils to textiles to plastics -- and mingle with the artists and scientists, at "Cures are An Art Form."

Proceeds from "Cures Are an Art Form" and the upcoming May 14 fundraising auction at the DIA (open to ticketed guests only) will finance more of the Taubman Institute's Emerging Scholars grants.  

Aimed at launching the laboratories of U-M's best and brightest young doctor-scientists, these grants of $50,000 per year for three years help fuel the next generation of medical breakthroughs.

In just a few short years, Taubman Emerging Scholars have initiated nine human clinical trials of new treatments in fields ranging from cancer to inflammatory diseases. With 16 Emerging Scholars now being supported – and two dozen more worthy candidates vetted and ready for funding – it’s a program that aims for, and achieves, fast results.

 

Cures are An Art Form


Location: Populux, 4120 Woodward Ave, Detroit  (inside the Majestic Theater complex)
Door time: 6 p.m.
Open bar (beer & wine) 6-8 p.m.
Cash bar 8-10 p.m.
Light refreshments served
Entertainment by Ethan Daniel Davidson and others
Tickets: $50  ~ Purchase via ticketweb

(Note: Advance purchasers will also receive one free ticket to the Populux event, up to June 20, of their choice. Movement weekend excluded.)


For more information about tickets to the gala and fine art auction to be held May 14, visit www.TaubmanArtAndScience.org



 

Subcategories

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift